These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29361493)

  • 1. Many Faces of Fabry's Cardiomyopathy.
    Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
    [No Abstract]   [Full Text] [Related]  

  • 2. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy.
    Teragaki M; Tanaka A; Akioka K; Lan HT; Nishi Y; Yamano T; Yoshikawa J
    Jpn Heart J; 2004 Jul; 45(4):685-9. PubMed ID: 15353880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
    Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
    [No Abstract]   [Full Text] [Related]  

  • 5. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
    Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
    Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
    Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.
    Frustaci A; Chimenti C; Ricci R; Natale L; Russo MA; Pieroni M; Eng CM; Desnick RJ
    N Engl J Med; 2001 Jul; 345(1):25-32. PubMed ID: 11439944
    [No Abstract]   [Full Text] [Related]  

  • 9. Fabry's disease with LVOT obstruction: diagnosis and management.
    Blount JR; Wu JK; Martinez MW
    J Card Surg; 2013 Nov; 28(6):695-8. PubMed ID: 23992477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac manifestations in Fabry disease].
    Lappegård KT; Aass H
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease?
    Stöllberger C; Finsterer J; Voigtländer T; Slany J
    Z Kardiol; 2003 Nov; 92(11):966-9. PubMed ID: 14634768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice.
    Moreth K; Afonso LC; Fuchs H; Gailus-Durner V; Katus HA; Bekeredjian R; Lehman L; Hrabě de Angelis M
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):669-79. PubMed ID: 25627778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
    Chaves-Markman ÂV; Markman M; Calado EB; Pires RF; Santos-Veloso MAO; Pereira CMF; Lordsleem ABMDS; Lima SG; Markman Filho B; Oliveira DC
    Arq Bras Cardiol; 2019 Jul; 113(1):77-84. PubMed ID: 31291414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heart in Anderson Fabry disease.
    Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
    Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
    Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
    J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Urinary Mulberry Bodies Leads to Diagnosis of Fabry Cardiomyopathy: A Simple Clue in the Urine Sediment.
    Yano T; Takahashi R; Yamashita T; Nagano N; Ishikawa A; Sakurai A; Maruyama H; Miura T
    Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203563
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.